Drug Science

More details coming soon!

World famous brain scientist Professor David Nutt will cover the range of understandings that modern science has given us into the evolution and function of the brain, along with the massive growth of neuropsychopharmacology, particularly in relation to the use of psychedelics (e.g. LSD, Psilocybin) and entactogens (e.g. MDMA)

David Nutt is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London. Here he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments. He has published over 450 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 30... books, including one for the general public, Drugs: without the hot air, that won the Transmission Prize in 2014. He is currently the President of the European Brain Council and Founding Chair of DrugScience.org.uk (formerly the Independent Scientific Committee on Drugs (ISCD). Previously he has been president of the British Association of Psychopharmacology, the British Neuroscience Association and the European College of Neuropsychopharmacology.
He broadcasts widely to the general public both on radio and television. In 2010 The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist in the list. In 2013 he was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science and in 2017 a Doctor of Laws hon causa from the University of Bath
See More

Renowned neuroscientist Professor David Nutt is in conversation with Salon London’s Helen Bagnall about his plans to bring liver friendly hangover-free synthetic alcohol to market by 2020, the surprising difficulties British Universities face conducting essential research in to effective treatments for anxiety and depression, and the powerful role the British government plays in preventing academics publishing research findings which might contravene their political worldview (something Professor Nutt knows only too well).

[Home Secretary] Javid said: “Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory ... but is in no way a first step to the legalisation of cannabis for recreational use.”
Well we'll see, won't we?

Around the world, the legal status of cannabis is changing. Now is the time to ask hard questions: - With increasing evidence supporting the medicinal use of cannabis, what shifts policy? - Is it possible to change the law in a way that maximises benefit, and minimises harm?
Free discussion event in London - 26th September - with some of the UK's leading researchers, including our Prof Val Curran

Antidepressants don't work well for up to 50% of people - perhaps psychedelics could be the next powerful therapeutic family of drugs for mental health conditions.
Have a look at the Psychedelic Society's campaign to reschedule psilocybin out of Schedule 1 here: http://psychedelicsociety.org.uk/…/psyc hedelics-for-mental-…

Check out our new offering of videos, discussions and TED talks by some of our committee members including Prof Val Curran, Steve Rolles and Prof David Nutt - cannabis, psychedelics, drug policy and more! http://www.drugscience.org.uk/resources